Leishmaniasis vaccine research : current status and new directions

Topuz Ata, Derya and Ata, Anil and Carter, Chris (Katharine C.) (2026) Leishmaniasis vaccine research : current status and new directions. Parasitology. pp. 1-12. ISSN 0031-1820 (https://doi.org/10.1017/S0031182025101522)

Preview

Text. Filename: Ata-etal-Parasitology-2026-Leishmaniasis-vaccine-research-current-status-and-new-directions.pdf Final Published Version License: Download (1MB)| Preview

Abstract

Leishmaniasis is a neglected parasitic disease responsible for significant morbidity and mortality. Currently, there is no vaccine approved for clinical use. Therefore controlling infections in infected individuals depends on interventions to prevent infected female sand flies from biting humans, treatment of clinical infections or alternative treatment methods. This review focuses on the types of vaccine developed to control leishmaniasis and which vaccines have made it through to clinical trials. It also discusses the role CRISPR technology may play in improving vaccine candidates design.

• Share and Export
  

  Simple MetadataEP3 XMLRIS (EndNote Online, Zotero, Ref manager, etc)AtomDublin CoreJSONMPEG-21 DIDLMultiline CSVASCII CitationRDF+XMLEndNoteRIOXX2 XMLRDF+N3METSRDF+N-TriplesHTML CitationMODSOpenURL ContextObject in SpanBibTeXOpenURL ContextObjectReferData Cite XMLRefWorks
• Item metadata

  Item type:	Article
  ID code:	95304
  Dates:	Date Event 7 January 2026 Published 7 January 2026 Published Online 13 December 2025 Accepted 30 September 2025 Submitted
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	14 Jan 2026 16:36
  Last modified:	29 Jan 2026 08:48
  URI:	https://strathprints.strath.ac.uk/id/eprint/95304